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A B S T R A C T
Results of the retrospective, population-based study, 2000–2010, on inflammatory bowel disease, ulceratice colitis
(UC) and Crohn's disease (CD), from Zadar County, have been presented and compared with world experience and com-
parative data from Primorsko-Goranska and Vukovarsko-Srijemska Counties. The average incidence rates (per 100 000)
were 8.2 and 8.4, for UC and CD, respectively. Prevalence rates, at the end of the follow up, were 133.9 for UC and 111 for
CD. Constant increase in the incidence rates for both, UC and CD, have been recorded, for CD more prominently in the
second part of the follow up, 2006–2010. Prevalence rates have being continuosly rased for both diseases, data for UC ex-
ceeding that for CD. Results of data comparison among the counties contribute in favour to the hypothesis of Zadar
County as a rapidly developing area and strongly argue against the existence of the North-South gradient between Vuko-
varsko-Srijemska and Zadar Counties.
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Introduction
Inflammatory bowel disease (IBD), Crohn's disease
(CD) and ulcerative colitis (UC), are two similar chronic
inflammatory disorders of the intestine, typically pre-
sented with the exchange of exarcebations and remis-
sions1. Exacerbation symptoms include abdominal pain,
diarrhoea, gastrointestinal bleeding, raised body temper-
ature, fatigue and weight loss. Long disease duration is
also associated with malnutrition and the development
of chronic intestinal and extraintestinal complications2.
In the case of CD, chronic intestinal complications usu-
ally require surgical interventions3. Extraintestinal com-
plications are the result of chronic inflammation associ-
ated with metabolic disturbances and immune activation
and can be presented with a variety of manifestations, in-
cluding skin, joint, eye and the hepatobiliary system
disorders4. Due to many symptoms and the chronic cour-
se characterized with the development of complications,
IBD have also a substantial impact on the quality of life
and difficulties of living with chronic disease issues5.
Although both diseases share many clinical and pa-
thogenetic features, they yet show differences, sufficient-
ly enough to acquire characteristics as two separate dis-
orders. In CD, pathologic changes usually involves ter-
minal ileum and the ascending colon, but can affect any
part of the gastrointestinal system, from the mouth to
the anus. Inflammatory process is associated with lym-
phocyte infiltration and granulomas formation and en-
compasses the whole wall thickness, with spreading also
to the mesenterial lymph nodes, mesenterium and the
peritoneal cavity. It is characterized with deep ulcers and
fissures, which are later substituted with progressive fi-
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brosis and the formation of stenosis and fistulas. In UC,
the inflammatory process maintains localised in the mu-
cosa and is mediated mainly by neutrophil granulocytes
infiltration. It is characterized with the crypt abscess for-
mation and the hypertrophy of the rest of the mucosa,
the state known as pseudopolyposis, which later during
the course of the disease reverts to the mucosal atrophy
and the intestinal retraction. Pathologic process typically
involves the rectum and may spread continuously to the
colon, sometimes affecting the entire colon2,4.
In spite of much progress made in understanding the
pathophysiology of IBD, it is still largely unknown. Re-
cent findings suggest the disruption of the gut immune
homeostasis and the epithelial cells regulatory mecha-
nisms, which then lead to the abnormal immune re-
sponses to commensal bacteria and chronic intestinal
inflammation6. Although certain IBD susceptibility ge-
nes have been identified so far, it does not contribute
much to planning prevention, as evidence suggest that
changes in lifestyles and environmental exposures are
those factors that drive the spread and clinical expres-
sion of these diseases, while genetic factors have only the
permissive role7,8. In line to this, recent epidemiologic
studies indicate rapid changes in the epidemiologic pat-
terns of IBD in the last two decades. Traditionally, the
highest incidence and prevalence of UC and CD have
been reported in the developed areas of Northen Europe
and North America, with the gradient observed to exist
from North to South and, to a lesser degree, from West to
East1,9. Some theories have been coined to explain ob-
served differences in the spread of IBD. An explanation
provided to support the North to South gradient includes
differences in climate and the number of sunny days per
year, between the northern and the southern countries9.
The Hygiene hypothesis has been used to explain the
West to East gradient. It indicates that the high sanita-
tion level, wide antibiotics use and mandatory vaccina-
tion are these factors which, in the developed Westernian
countries, cause poor immunization of children to micro-
bial antigens and the breakdown of the immunologic tol-
erance later in life, leading to the development of IBD10.
In contrast to the traditional epidemiologic situation,
IBD has now being emerged in regions where they have
rarely been, or have not been at all registered before,
such as countries of Eastern Europe, continental and
South-East Asia and North Africa11–14. In developed coun-
tries, stagnation, or a slowdown, has been recorded1. It
has been generally accepted that these recent epide-
miologic features indicate emergency of IBD as a global
disease, which is likely to correspond with the western-
ised lifestyles, including factors such as smoking, diets
high in fat and sugar, widespread use of medications and
psycho-social stress15.
The epidemiologic studies on IBD in Croatia have al-
ready been performed in Primorsko-Goranska (P-G) and
Vukovarsko-Srijemska (V-S) Counties (Figure 1). In this
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Fig. 1. Division of Croatia on counties. Counties of the interest for this paper: Zadar County, Primorsko-Goranska and Vukovarsko-Srijemska Counties.
paper, the results for Zadar County have been presented




Patients diagnosed with IBD (UC or CD) and living in
Zadar County were included in the study. According to
the last census, 2001, there were 162 045 citizens in
Zadar County, distributed on the surface area of 3646
km2, which makes density of 44.4 citizens per 1 km2. The
prevalent contribution was from the urban area (61.7%).
The total number of eligible patients was 397. Of
them, 217 were diagnosed with UC (54.6%) and 180 with
CD (45.4%). There were 243 (61.2%) males and 154
(38.8%) females. The inclusion criteria were defined as
the combination of clinical symptoms and signs and en-
doscopic, radiology and hystopathology reports. Patients
with nonclassified IBD and those with coprocultures pos-
itive on bacterial causes of diarrhoea, or those previously
receiving antibiotics, were excluded from the analysis.
Methods
The same design as in the recently reported study
from V-S County has been applied. For the beginning, the
patient list was formed, using documentation of the Gen-
eral Hospital Zadar and two private enterprises. The
10-year period, 2000–2010, was used. Prevalence data
were estimated according to the number of patients diag-
nosed with IBD until January 1st 2010, inclusive. Pa-
tients were contacted personally, or by phone, and inter-
viewed according to two types of questionnaires, adapted
to data collection on either the incidence or prevalence of
IBD.
Protocols were identical in parts addressing issues
such as: patients general data, demographic features, ed-
ucation, employment status, family history of IBD and
risk factors. Some parts of both questionnaires were de-
voted specifically to disease data, including information
on: the type and time of the diagnosis, symptoms and
their duration prior to the first medical check up, body
weight at the time of the first physical examination,
weight loss in the last three months, performed diagnos-
tic procedures and the extent of a disease. The protocol
adapted to data collection on prevalence of IBD was ex-
tended for the part addressing issues, such as: the natu-
ral history of a disease, the presence/absence of the intes-
tinal and extraintestinal complications, the number and
types of surgical interventions and the results of patho-
histological examinations. According to these latter data,
phenotypes of both, UC and CD, were determined, by us-
ing the Montreal classification16.
Statistics
Statistical analyses were performed by using statisti-
cal software package SPPS 10.0 (SPSS for Windows,
SPSS Inc. Chicago IL, USA). Categorical data were pre-
sented as absolute frequences and percentages.
Differences between groups were assessed by using the
student's t-test for two independend samples. Absolute
frequences were assessed by using c2-test and, where ap-
propriate, Fisher exact test. The level of significance of
p<0.05 was considered statistically significant.
Results
Demographic data analysis
Comparative analysis of demographic features be-
tween the two patient groups showed that males were
prevalent in both patient groups and that there were no
differences in males to females proportions, depending
on the type of diagnosis (Table 1). Differences between
patients with UC and CD were found in: 1) marital status
(higher percentage of married persons among those diag-
nosed with UC), 2) level of education (the prevailing pro-
portion of those with secondary school against those with
lower level education, among patients with CD), 3) the
status of employment (unemployed persons were more
frequently presented among patients with CD, while
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TABLE 1.
DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH






Distribution of subjects by gender
M 128 (59) 115 (63.9)
0.319
F 89 (41) 65 (36.1)
Distribution of subjects by marital status
Married 181 (83.4) 106 (58.9)
<0.05
Unmarried 29 (13.4) 72 (40.0)
Divorced 2 (0.9) 1 (0.6)
Widow(er) 5 (2.3) 1 (0.6)
Distribution of subjects by resident status
Immigrant to Zadar
County
35 (16.1) 15 (8.3)
<0.05
Born in Zadar County 182 (83.9) 165 (91.7)
Distribution of subjects by the level of education
Primary school 10 (4.6) 2 (1.1)
<0.05
Vocational school 6 (2.8) 5 (2.8)
Secondary school 148 (68.2) 144 (80.0)
University education 53 (24.4) 29 (16.1)
Distribution of subjects by the employment status
Employed 126 (58.1) 110 (61.1)
<0.05
Unemployed 23 (10.6) 34 (18.9)
Retired 48 (22.1) 18 (10.0)
Housekeepers 12 (5.5) 4 (2.2)
Students 8 (3.7) 14 (7.8)
* c2-test
those retired were more frequently presented in the
group of patients with UC) and 4) the resident status
(higher percentage of immigrants among patients with
UC) (Table 1). In addition, patients with CD were, in av-
erage, younger then those with UC (31.9 and 42.2 years,
respectively) (Figure 2).
The average incidence rates for UC and CD, in Zadar
County, for the 10-year period of observation, 2000–2010,
were 8.2 and 8.4 per 100 000, respectively. Prevalence
rates, estimated at the end of the follow up, were 133.9/
100 000 for UC and 111/100 000 for CD. An increase in
the incidence rates for both, UC and CD, have been re-
corded, more prominently visible for CD in the second
part of the follow up, 2006–2010 (Figure 3).
In the period of observation, prevalence rates have be-
ing continuosly rased for both diseases, data for UC ex-
ceeding that for CD (Figure 4). Two time points of accel-
eration in prevalence rates uprise can be observed, in-
cluding years 2004 and 2006 (Figure 4).
The incidence and prevalence data for Zadar County
were compared with the corresponding data for two
other counties, P-G and V-S, where the epidemiologic
studies have already been performed. However, this com-
parison was restricted to the period of the data overlap,
that is, for the years 2000–2004 (Tables 2–4). Based on
these comparisons, it is visible that the average incidence
rate for UC is higher in Zadar County than in P-G
County (6.2 against 4.6) (Table 2), while the highest av-
erage incidence rate for CD is in P-G County (6.5), over-
coming that in Zadar County (5.2) (Table 3). Prevalence
rates for both diseases, UC and CD, are the highest in
P-G County, the difference particularly prominent for
CD, compared to Zadar County (Table 4). In comparison
to these two counties, in V-S County, much lower corre-
sponding values for the average incidence and prevalence
rates have been recorded, especially for CD (Table 2–4).































































Fig. 4. Prevalence rates for UC and CD across the years 2000–2010.
TABLE 2.
THE INCIDENCE RATES FOR UC FOR THE PERIOD 2000–2004,









2000 4.3 1.0 6.9
2001 5.5 2.0 5.6
2002 4.9 1.0 3.9
2003 8.0 2.0 3.3
2004 8.6 2.0 3.3
Average 6.2 1.6 4.6
TABLE 3.
THE INCIDENCE RATES FOR CD FOR THE PERIOD 2000–2004,









2000 3.7 0.5 7.9
2001 5.5 0.0 5.9
2002 5.5 1.0 5.9
2003 3.0 0.0 5.9
2004 8.6 1.0 7.2
Average 5.2 0.5 6.5
TABLE 4.
PREVALENCE RATES FOR UC AND CD FOR THE YEAR 2004,










Ulcerative colitis 74.7 19.0 84.9
Crohn's disease 45.0 6.3 83.7
Analysis of symptoms, signs and phenotypes
Analysis of symptoms and signs at the time of diagno-
sis showed certain differences in clinical presentation of
UC and CD (Table 5). Also, a statistically significant dif-
ference was found in the average duration of symptoms,
prior to the diagnosis. In patients with UC, it lasted in
average 3.5 months and in patients with CD 6.6 months
(Figure 5).
The most common clinical presentation of patients
with UC included moderately frequent (4–7 times per
day) bloody and slimy stools. In the case of CD, it was ab-
dominal pain and more general symptoms, including fa-
tigue, fever and weight loss (Table 5).
Analysis of phenotypes, based on using the Montreal's
classification, indicated the extent of either of a disease.
Patients with UC were most commonly presented with
the phenotype E3 (indicating extensive colitis, or pan-
colitis). However, the difference did not reach the signifi-
cance level, not either in relation to two other pheno-
types (E1 – proctitis and E2 – the colorectum and the left
side of the colon) (c2-test, p=0.81), nor in relation to
males/females distribution (c2-test, p=0.21) (Figure 6).
The most common phenotypes, in patients with CD,
based on using the Montreal's classification, were
A2L1B1 (20.8%), A2L3B1 (13.9%) and A2L2B1 (8.1%),
where A indicates age, L – localisation and B – disease be-
haviour (Figure 7). By considering particular respective
parameters, then significantly higher percentage of pa-
tients were in the age group A2 (17–40 years) (62.8%)
and had disease localisation in the terminal ileum (L1)
(41.6%), or in the terminal ileum and the colon (L3)
(35.6%), or in the colon alone (L2) (22.8%). With respect
to disease behaviour, the significantly highest percentage
of patients (72.8%) had the phenotype B1 (noncompli-
cated disease) (Table 6).
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TABLE 5.
SYMPTOMS AND SIGNS AT THE TIME OF DIAGNOSIS FOR








Yes 83 (38.2) 71 (39.4) p >0.05*
No 134 (61.8) 109 (60.6)
Abdominal pain
Yes 134 (61.8) 135 (75.0) p<0.05*
No 83 (38.2) 45 (25.0)
Bloody and slimy stool
Yes 205 (94.5) 51 (28.3) p<0.05†
No 12 (5.5) 129 (71.7)
The number of stools per day
1–3 50 (23.0) 81 (45.0) p<0.05†
4–7 151 (69.6) 91 (50.6)
>8 16 (7.4) 8 (4.4)
Fatigue
Yes 107 (49.3) 120 (66.7) p<0.280*
No 110 (50.7) 60 (33.3)
Fever
Yes 49 (22.6) 86 (47.8) p<0.006*
No 168 (77.4) 94 (52.2)
Weight loss (kg) in the last three months
Yes 87 (40.1) 112 (62.2) p<0.05*
No 130 (59.9) 68 (37.8)





























Fig. 5. Duration of symptoms prior to the diagnosis for ulcerative














Fig. 6. The distribution of phenotypes, identified according to the



























































































Fig. 7. The distribution of phenotypes, identified according to the
Montreal's classification, in patients with CD.
Analysis of intestinal and extraintestinal
complications
Analysis of intestinal complications, between the two
patient groups, showed significantly higher participation
of complications that require surgical treatment in pa-
tients with CD, including perforation, fistula, abscess
and ileus. The percentage of patients already experi-
enced some surgical treatments was also higher among
those diagnosed with CD (Table 7). Intestinal complica-
tions, found to be more frequently presented in patients
with UC, included massive rectal bleeding, toxic mega-
colon and colorectal cancer (Table 7).
With respect to extraintestinal complications, the re-
sults of comparison between the two patient groups
showed statistically significant differences in the follow-
ing symptoms: erythema nodosum, aphtous stomatitis
(prevalently recorded in patients with CD), pyoderma
gangrenosum, primary sclerosing cholangitis and throm-
boembolic events (more frequently presented in patients
with UC) (Table 8).
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TABLE 6.
PHENOTYPES, IN PATIENTS WITH CD, ACCORDING TO THE
PARTICULAR RESPECTIVE PARAMETERS, INCLUDING AGE (A),
LOCALISATION (L) AND DISEASE BEHAVIOUR (B)
Fenotype 1 2 3 p*
A 11 (6.1%) 113 (62.8%) 56 (31.1%) p<0.01*
L 75 (41.6%) 41 (22.8%) 64 (35.6%) p<0.01*
B 131 (72.8%) 22 (12.2%) 27 (15.0%) p<0.01*
* c²-test
TABLE 7.
INTESTINAL COMPLICATIONS, DISTRIBUTED BETWEEN







Yes 6 (2.8) 3 (1.7)*
No 210 (97.3) 177 (98.3)
Toxic megacolon
Yes 5 (2.3) 0 (0.0)*
No 212 (97.7) 180 (100)
Intestinal perforation
Yes 2 (0.9) 12 (6.7)*
No 215 (99.1) 168 (93.3)
Carcinoma of the colorectum
Yes 6 (2.8) 2 (1.1)*
No 211 (97.2) 179 (99.4)
Fistula
Yes 0 (0.0) 24 (13.3)*
No 217 (100) 163 (90.6)
Abscess
Yes 0 (0.0) 20 (11.1)*
No 217 (100) 164 (91.1)
Ileus
Yes 0 (0.0) 25 (13.9)*
No 217 (100) 155 (86.1)
Operative treatment
Yes 14 (6.5) 39 (21.7)*
No 203 (93.5) 141 (78.3)
* c2-test <0.001
TABLE 8.
EXTRAINTESTINAL COMPLICATIONS, DISTRIBUTED BETWEEN








Yes 33 (15.2) 29 (16.1)
>0.05*
No 184 (84.8) 151 (83.9)
Sacroiliitis
Yes 13 (6.0) 12 (6.7)
>0.05†
No 204 (94.0) 168 (93.3)
Erythema nodosum
Yes 15 (6.9) 16 (8.9)
<0.05†
No 202 (93.1) 164 (91.1)
Pyoderma gangrenosum
Yes 5 (2.3) 0 (0.0)
<0.05†
No 212 (97.7) 180 (100)
Aphtous stomatitis
Yes 20 (9.2) 41 (22.8)
<0.05*
No 197 (90.8) 139 (77.2)
Gallstones
Yes 21 (9.7) 18 (10.0)
>0.05†
No 196 (90.3) 162 (90.0)
Renal stones
Yes 13 (6.0) 10 (5.6)
>0.05†
No 204 (94.0) 170 (94.4)
Eye inflammation
Yes 17 (7.8) 12 (6.7)
>0.05†
No 200 (92.2) 168 (93.3)
Primary sclerosing cholangitis
Yes 4 (1.8) 1 (0.6)
<0.05†
No 213 (98.2) 179 (99.4)
Thromboembolic events
Yes 4 (1.8) 1 (0.6)
<0.05†
No 213 (98.2) 179 (99.4)
* c2-test, † Fisher’s exact test
Familiar gathering of IBD was explored by interview-
ing patients and the controls on first-line relatives hav-
ing IBD (Table 9).
Disscusion
Comments on demographic data analysis
Demographic data analysis showed that sex prefer-
ences, according to whether a patient is diagnosed with
UC, or CD, have not been found, in spite of slightly prev-
alent males to females proportion, found in both patient
groups (59% for UC and 63.9% for CD) (Table 1). It has
been suggested, according to the past experience, that F
sex is preferentially associated with the diagnosis of CD,
while UC is likely to be slightly more common in males1.
However, recent studies, performed mostly in areas with
fastly increasing incidence of IBD, show rather variable
results15,17,18. In the recently performed study, in V-S
County, sex preferences, according to the type of diagno-
sis of IBD, also have not been found19. Taken together, it
seems that sex preferences, in relation to the type of di-
agnosis of IBD, might be only secondary to differences in
lifestyles between men and women, but this statement
needs further confirmation.
In this patient sample, patients diagnosed with UC
were, in average, significantly older, than patients diag-
nosed with CD (Figure 1). More precisely, the majority of
patients with CD were in the age range from around 20
to less then 50, while patients with UC were mostly
placed within the age range less then 30 to around 60,
the results showing a ten-year difference in the age range
between the groups (Figure 2). Evidence from the litera-
ture indicates earlier time of disease occurence for CD,
than for UC, the factor that may influence differences in
the average age of patients with UC and CD, in our re-
sults17,18,20. Results from the recent epidemiologic study,
performed in V-S County, also indicate older average age
for patients with UC, than for those with CD, with the
note that for patients with CD, two age peaks have been
recorded, one in younger and the other in the middle
aged groups19. It is possible that observed differences in
the average age, between patients with UC and CD, in
this study, are in the background of other differences,
found to exist in patients demographic data, including
those related to the marital status, level of education, the
employment status and the resident status (Table 1). As
in the study from V-S County, in Zadar County, there was
also higher percentage of immigrants among patients
with UC, than among patients with CD, indicating possi-
ble role of the immigrant status as a risk factor for UC19.
This hypothesis is also supported by the results of epide-
miologic studies performed on migrant populations all
around the world21,22.
Comments on the incidence and prevalence data
According to our results, in Zadar County, in the last
decade, 2000–2010, there was the constant increase in
the incidence and prevalence rates for both, UC and CD
(Figure 3 and 4). Although both diseases had almost the
same average incidence rate (8.2 and 8.4), graphical pre-
sentation indicated different time-trends for a particular
of two diseases (Figure 3). Based on the graphical presen-
tation, the incidence rates started to rise in 2002. Until
2005, UC showed a continuous course, while in the case
of CD, the course was rather scattered. The incidence
rates for UC exceeded those for UC. In the period from
2006 to 2010, this trend reverted to a domination of CD
over UC (Figure 3). These described time-trends can be
explained by the process of intensive migration, taking
place in Zadar County in years after the War in Croatia
(1991–1997). Namely, psycho-social stress and bad life-
styles, together with fast demographic changes, in the
long post-war period, could accelerate the occurence of
IBD, during the period 2002–2005, after a short period of
latency, 2000–2002 (Figure 3). After the year 2006, there
was a new wave of acceleration in the occurence of IBD,
especially emphasized in the case of CD, probably due to
the process of globalisation. Another contributing factor
could be due to the improvements in the endoscopic pro-
cedures and health care in general, in the last decades23.
This explanation is also supported by the graphical pre-
sentation of the time-trends in prevalence rates, showing
the similar time-points of acceleration, that is, in the
years 2004 and 2007 (Figure 4). Similar time-trends in
the incidence and prevalence rates of IBD, although at a
lower level, and with the same critical time-point, in the
year 2006, we could observed in the study recently con-
ducted in V-S County19. Observations, made in this study,
we provided with the same explanations as are these we
are now using in the case of Zadar County19.
Increasing incidence and prevalence rates of IBD,
with the predominant participation of UC over CD, place
Zadar County, similar to what was seen for V-S County,
into a group of developing areas of Europe19. There are
also some exceptions to this comparison. As visible on the
graph, Figure 3, more steepy increase in the incidence
rates for CD, compared to UC, in the period after the year
2006, is likely to take Zadar County on a step closer to
the developed countries of Europe and the world. In
terms of that, there is a general consensus that, in devel-
oped areas of the world, including North America, Can-
ada and Northern Europe, there is a trend of increase in
the incidence of CD and stabilisation, although at a rela-
tively high level, in the incidence of UC9,15,24,25. It seems,
according to our results, that Zadar County, in relation to
the occurence of IBD, is now at that position where some
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TABLE 9.
FIRST-LINE RELATIVES REPORTED AS HAVING IBD,
IN PATIENTS WITH IBD AND THE CONTROLS







c²-test (with Yates' correction); p<0.001
developed parts of Europe and the world were about two
decades ago. Related to this, the results of the European
IBD Collaborative Study (1991–1993) reported, for the
developed Northern parts of Europe, incidence rates for
CD of 7.0, that is similar to the average incidence rate of
8.4, estimated for Zadar County, for the period 2000–
20109. That some other, specific factor can operate lo-
cally, in Zadar County, it is illustrated by the fact that the
incidence rates for CD are yet comparable to those re-
corded in the developed areas of Europe, while the corre-
sponding data for UC are still considerable bellow the
level of the developed countries (6.2 against 11.8), indi-
cating more speedy rise in the incidence rates for CD
than for UC9. Otherwise, the incidence rates for CD that
exceed those for UC can only be a marker of very fast de-
velopment of the Zadar Region. That Zadar Region is not
an isolated example in this sense, it can be supported by
the similar reports coming from other minor surround-
ings in Europe, such as the Northern France, or even the
Southern Greek26,27.
In favour to the hypothesis that the observed time-
-trends for UC and CD, in Zadar County, follow the West
to East gradient pattern and rapidly developing areas
patterns, rather than the North to South gradient pat-
tern, can also be supported by our results arised from the
comparison of all three counties, including also P-G and
V-S Counties, in which the epidemiologic studies have al-
ready taken place (Table 2–4). However, this comparison
has a limitation that includes the restricted time of the
overlap between the data; that means, the analysis was
done for the early period, 2000–2004, while data compar-
ison for the second, more dynamic period, 2006–2010, is
missing. Yet, available data implicate P-G County as the
most developed one, based on the highest prevalence
rates for both, UC and CD (84.9 and 83.7, respectively).
Zadar County is likely to be classified, then, as the rap-
idly developing area, as its prevalence rate for UC, but
not for CD, is approaching that of P-G County (Table 4).
Our results of the comparison of the incidence data,
among the counties, can also contribute in favour to the
hypothesis of Zadar County as a rapidly developing area
(Tables 2 and 3). In this sense, and according to the
known pattern for developing areas, the average inci-
dence rate for UC, in Zadar County, exceeds that re-
ported for P-G County (6.2/4.6), while the average inci-
dence rate for CD is slightly bellow that of P-G County
(5.2/6.5), with the note that these data are related to the
period when the incidence rates for CD have not started
yet to rapidly rise (Tables 2 and 3, Figure 3). In line to
this provided explanation for Zadar County as a rapidly
developing area, experiences of a large-scale indicate
that, in developing areas, the increase in incidence of UC
precedes the increase in incidence of CD. In developed
countries, there is the turning on, from the domination
of UC towards the higher incidence of CD1.
In comparison to P-G and Zadar counties, V-S County
is still keeping at the low-level of the incidence and prev-
alence rates for IBD, similar to some other developing ar-
eas in Eastern Europe11,12. Moreover, data for V-S County
are far bellow those for Zadar County, although V-S
County is located in the northern part and Zadar County
in the southern part of Croatia. This fact strongly argues
against the existence of the North to South gradient, at
least in our country.
Comments on the analysis of symptoms,
signs and phenotypes
Our results indicate longer duration of symptoms and
signs prior to the diagnosis, in patients with CD (an aver-
age 6.6 months), in comparison to patients with UC (an
average 3.5 months) (Figure 5). These results are similar
to what has recently been reported for V-S County and
what is cited elsewhere in the literature, indicating the
problem of a delay in diagnosing CD as one of a large
scale28,29. This may be associated with the obscure local-
isation of CD in the terminal ileum, differences in the
pathologic processes between CD and UC and, accord-
ingly, in clinical manifestations of these two diseases. Re-
lated to this, our results indicate more general symptoms
as the first clinical manifestations of CD, in contrast to
the local, intestinal symptoms which are likely to corre-
late with the onset of UC (Table 5). These general symp-
toms, in patients with CD, as other authors also state,
are therefore difficult to observe, until some more pro-
nounced symptoms, later during the course of the dis-
ease, do occur, such as anemia, or weight loss29. Another
contributing factor to a longer duration of symptoms be-
fore the diagnosis, in patients with CD, may be younger
age at disease onset, compared to UC. In Zadar County
cohort, it is clearly illustrated with the average age of
31.9 years, in patients with CD, in contrast to 42.2 years,
in patients with UC (Figure 2). Namely, as we have al-
ready concluded, in the study conducted in V-S County,
young patients might be less sensitive in recognising
early disease symptoms28.
An alternative explanation is that clinical presenta-
tion of IBD may be a consequence of the extent of a dis-
ease. In this patient group with UC, the most common
phenotypes, although the distribution not reaching the
statistically significant difference, were E3 (extensive co-
litis and pancolitis) and E2 (the rectum and the left co-
lon) (Figure 6). These results, indicating rather extended
type of disease, even indirectly, suggest a long disease du-
ration. Namely, as according to the evidence, the proxi-
mal extent of inflammation has a tendency to progress
over time30. In terms of that, results of some studies indi-
cate that after 20 years of disease duration, a large pro-
portion of patients are likely to acquire the extended type
of disease, in the form of pancolitis31. Another explana-
tion may be that, in this patient group, biologic treat-
ment, known to strongly modulate the natural course of
the disease, have might been missing32. Based on this dis-
cussion, however, it becomes clear that clinical presenta-
tion of the Zadar County UC cohort, with 4–7 bloody,
slimy stools per day, that correspond with mild to moder-
ate disease severity grade, can not add much information
to the prognosis, because the evidence says that the dis-
ease activity shows a tendency to decrease over time33,34.
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With respect to patients with CD, the most common
phenotype, according to the Montreal's classification,
corresponds with young adult age (17–40 years), non-
complicated (inflammatory) behaviour and disease local-
isation in the terminal ileum, or the ileocolon (Figure 7,
Table 8). Based on the world experience, the prevalent lo-
calisation of CD, at the time of diagnosis, is the ileoco-
lonic disease, as it has been also reported for the cohort
from V-S County28,30,35. The bias towards isolated small
bowel disease, in the Zadar County patient group, is not
likely to reflect their average younger age, compared, for
example, to the cohort from V-S County (around 31 and
41 years, respectively), as the localisation of CD, unlike
disease behaviour, is likely to maintain stable over ti-
me30,36. Related to this fact, noncomplicated (inflamma-
tory) behaviour of CD, dominating in our sample, and
presented mainly with general symptoms, is more likely
to reflect younger average age at disease onset, compared
to the cohort from V-S County, where mainly the stric-
turing disease behaviour (phenotype B3), indicating lon-
ger disease duration, has been recorded28. The question
which seeks for an answer might be, whether the rapidly
increasing incidence rates of CD, in fastly developing ar-
eas such Zadar County is likely to be, could precipitate
the disease gathering in younger age agroups?
Comments on complications
In line with what was expected according to the natu-
ral course of IBD, intestinal complications requiring sur-
gical treatment, including perforation, fistula, abscess
and ileus, have been typically observed in patients with
CD, while in patients with UC, they have been almost
completely absent (Table 9). Yet, the percentage of pa-
tients with CD who needed surgical treatment (21,7%)
did not reach the levels cited in some large epidemiologic
studies37,38. For this disproportion, many factors can be
accounted for, including changes in the natural course of
this disease over time, improvements in diagnostics and
treatment, or some specific factors which may affect the
natural course of the disease, opperating in some local
surroundings, as Zadar County is. Or, simply, lover level
requirements for surgical treatments, in this patient
group with CD, can be associated with their relatively
younger average age.
In contrast to patients with CD, patients with UC, in
our sample, are more likely to develop complications
which are due to overwhelming inflammation, such as
massive rectal bleeding and toxic megacolon (Table 9).
According to our results, also, colorectal cancer, a known
late-onset complication of IBD, is, as expectedly, more
pronounced, although at the low level, in relation to UC
(Table 9)39.
With respect to the extraintestinal complications, pa-
tients in this sample were mainly presented with immu-
nologically mediated complications, except for tromboem-
bolic events, found in patients with UC. These findings
are likely to indicate close associations of these complica-
tions with chronic inflammation (Table 10)39. When com-
parisons with the results of the study from V-S County
had been made, it became clear that, in patients with CD,
from Zadar County, unlike to those from V-S County,
usual skin disorders, including aphtous stomatitis and
erythema nodosum, were the prevailing extraintestinal
signs, while there were no clinically more strongly de-
fined entities, such as ankylosing spondylitis28. The dif-
ference is probably reflecting differences in average age
and disease duration between the two groups, or in some
other, genetical, or environmental factors39. That con-
genital factors, either genetical, or acquired ones, gath-
ered within some families, may affect the natural course
and clinical presentation of IBD, it is supported by the re-
sults of this study, showing significantly higher number
of persons with IBD among first-order relatives of pa-
tients, compared to the controls (Table 11).
Conclusions
Croatia, with its unique geogaphical location, at the
border between the East and the West of Europe, and by
encompassing the northern, continental, and the south-
ern, coastal parts, is likely to be an ideal area for testing
the West to East and the North to South gradient hy-
potheses of IBD spreding. In addition, Croatia has expe-
rienced fast demographic and social changes in the re-
cent past. As our results indicate, here, on the relatively
small surface area, great changes in time-dependent
trends in the incidence and prevalence rates of IBD, in
the last two decades, can be noticed. Based on the com-
parative analysis which included three differently posi-
tioned and unequally developed counties, Primorsko-
-Goranska, Zadarska and Vukovarsko-Srijemska, it can
be concluded that the pattern of the epidemiologic chan-
ges of IBD is likely to strictly follow the rate of the eco-
nomic and social development of a particular area and, in
some way, can serve as a marker of the intensity of these
changes. Once again, this paper indicates towards the
values of performing epidemiologic and population-based
studies for assessing, not only changes in occurence of
IBD, but also changes in their natural courses and risk
factors.
R E F E R E N C E S
1. COSNES J, GOWER-ROUSSEAU C, SEKSIK P, CORTOT A, Gas-
troenterol, 140 (2011) 1785. DOI: 10.1053/j.gastro.2011.01.055. — 2.
BOUSVAROS A, ANTONIOLI DA, COLLETI RB, DUBINSKY MC, GLI-
CKMAN JN, GOLD BD, GRIFFITHS AM, JEVON GP, HIGUCHI LM,
HYAMS JS, KIRSCHNER BS, KUGATHASAN S, BALDASSANO RN,
RUSSO PA, J Pediatr Gastroenterol Nutr, 44 (2007) 653. — 3. VRABIE R,
IRWIN GL, FRIEDEL D, World J Gastrointest Endosc, 4 (11) (2012) 500.
DOI: 10.4253/wjge.v4.i11.500. — 4. DANESE S, FIOCCHI C, NEJM, 365
(2011) 1713. DOI: 10.1056/NEJMra1102942. — 5. HAUSER G, TKAL^I]
M, [TIMAC D, MILI] S, MIJANDRU[I] SIN^I] B, Coll Antropol, 35
(Suppl 2) (2011) 203. — 6. HISAMATSU T, KANAI T, MIKAMI Y,
YONENO K, MATSUOKA K, HIBI T, Pharmacology&Therapeutics, 137
Lj. Majnari} et al.: Epidemiology and Clinical Presentation of Inflammatory Bowel Disease, Coll. Antropol. 37 (2013) 4: 1161–1170
1169
(2013) 283. — 7. WALTERS TD, SILVERBERG MS, Can J Gastroenerol,
20 (2006) 633. — 8. NASER SA, ARCE M, KHAJA A, FERNANDEZ M,
NASER N, ELWASILA S, THANIGACHALAM S, World J Gastroenterol,
18 (5) (2012) 412. — 9. SHIVANANDA S, LENHARD-JONES J, LOGAN
R, FEAR N, PRICE A, CARPENTER L, von BLANKENSTEIN M, Gut,
39 (1996) 690. — 10. GENT AE, HELIER MD, GRACE RH, SWARBRICK
ET, COGGON D, Lancet, 343 (8900) (1994) 766. — 11. LAKATOS L,
MESTER G, ERDELJI Z, World J Gastroenterol, 10 (2004) 404. — 12.
GEHEORGHE C, PASCU O, GHEORGHE L, IACOB R, DUMITRU E,
TANTAU M, VADAN R, GOLDIS A, BALAN G, IACOB S, DOBRU D,
SAFTOIU A, Eur J Gastroenterol Hepatol, 16 (2004) 1153. — 13. PARK
JB, YANG S-K, BYEON J-S, PARK E-R, MOON G, MYUNG SJ, PARK
WK, YOON SG, KIM HS, LEE JG, KIM JH, MIN YI, KIM KY, Inflamm
Bowel Dis, 12 (2006) 1146. — 14. ABDUL-BAKI H, EIHAJJ I,
EL-ZAHAB L MN, AZAR C, AOUN E, ZANTOUT H, NASREDDINE W,
AYYACH B, MOURAD FH, SOWEID A, BARADA KA, SHARARA AI.
Inflamm Bowel Dis, 13 (2007) 475. — 15. MOLODECKY NA, SOON IS,
RABI DM, GHALI WA, FERRIS M, CHERNOFF G, BENCHIMOL EI,
GHOSH RPS, BARKEMA HW, KAPLAN GG, Gastroenterol, 142 (2012)
46. DOI:10.1053/j.gastro.2011.10.001 10. — 16. SATSANGI J, SIL-
VERBERG MS, VERMEIRE S, COLOMBEL J-F, Gut, 55 (2006) 749. —
17. GEARRY RB, RICHARDSON A, Inflamm Bowel Dis, 12 (2006) 936.
— 18. BERNSTEIN CN, WAJDA A, SVENSON LW, McKENZIE A, KOE-
HOORN M, JACKSON M, FEDARAK R, ISRAEL D, BLANCHARD JF,
Am J Gastroenterol, 101 (2006) 1559. — 19. PEZEROVI] D, KLARIN I,
@ULJ M, KHAZNADAR E, MAJNARI] LJ, V^EV A, Coll Antropol [in
press, 2013] — 20. LOFTUS CG, LOFTUS EV Jr, HARMSEN WS, ZINS-
MEISTER AR, TREMAINE WJ, MELTON LJ 3rd, SANDBORN WJ,
Inflamm Bowel Dis, 13 (2007) 254. — 21. PROBERT CS, JAYANTHI V,
PINDER D, WICKS AC, MAYBERRY JF, Gut, 33 (1992) 687. — 22. MAN-
GAT BK, EVASCHESEN C, LEE T, YOSHIDA EM, SALH B, Can J Gas-
troenterol, 25 (2011) 73. — 23. VATN MH. Environmental factors in the
epidemiology of inflammatory bowel disease. In: BAUMGART DC (Eds)
Crohn s Disease and Ulcerative colitis: from epidemiology and immu-
nobiology to a rational diagnostic and therapeutic approach (SSBM, LLC,
2012). — 24. LOFTUS EV, SCHOENFELD P, SANDBORN WJ, Aliment
Pharmacol Ther, 16 (2002) 51. DOI: 10.1046/j.1365-2036.2002. 01140.x.
— 25. BERNSTEIN CN, WAJDA A, SVENSON LW, MacKENZIE A,
KOEHOORN M, JACKSON M, FEDORAK R, ISRAEL D, BLANCHARD
JF, Am J Gastroenterol, 101 (2006) 1559. DOI: 10.1111/j.1572-
0241.2006.00603.x — 26. MOLINIE F, GOWER-ROUSSEAU C, YZET T,
MERLE V, GRANDBASTIEN B, MARTI R, LEREBOURS E, DUPAS J-L,
COLOMBEL J-F, SALOMEZ J-L, CORTOT A, Gut, 53 (2004) 843. — 27.
TRIANTAFILIDIS JK, KITIS G, KARAMANOLIS D, KARAGIANNIS I,
TZOURMAKLIOTITS D, Am J Gastroenterol, 18 (2005) 70. — 28. PE-
ZEROVI] D, @ULJ M, KLARIN I, MAJNARI] LJ, V^EV I, V^EV A, Coll
Antropol, 37 (2013) 919. — 29. BENEVENTO G, AVELLINI C, TER-
ROSU G, GERACI M, LODOLO I, SORRENTINO D, Expert Rev Gastro-
enterol Hepatol, 4 (2010) 757. DOI: 10.1586/egh.10.70. — 30. LOUIS E,
COLLARD A, OGER AF, Gut, 49 (2001) 777. DOI: 10.1136/gut.49.6. 777.
— 31. LANGHOLZ E, MUNKHOLM P, DAVIDSEN M, Scand J Gas-
troenterol, 31 (1996) 260. — 32. VERMEIRE G, van ASSCHE, RUT-
GEERTS P, Aliment Pharmal Ther, 25 (2006) 3. — 33. FROSLIE KF,
JAHNSEN J, MOUM BA, Gastroenterol, 107 (1994) 107. — 34. LANG-
HOLZ E, MUNKHOLM P, DAVIDSEN M, Gastroenterol, 107 (1994) 3. —
35. FARMER RG, HAWK WA, TURNBULL Jr RB. Gastroenterol, 68
(1975) 627. — 36. COSNES J, CATTAN S, BLAIN A, Inflamm Bowel Dis
8 (2002) 244. — 37. AGREZ MV, VALENTE RM, PIERCE W, MELTON
LJ III, van HEERDEN JA, BEART RW Jr, Mayo Clin Proc, 57 (1982) 747.
— 38. SILVERSTEIN MD, LOFTUS EV, SANDBORN WJ, Gastroenterol
117 (1999) 49. — 39. ABRAHAM C, Cho JH, N Engl J Med, 361 (2009)
2066. DOI: 10.1056/NEJMra0804647.
Lj. Majnari} et al.: Epidemiology and Clinical Presentation of Inflammatory Bowel Disease, Coll. Antropol. 37 (2013) 4: 1161–1170
1170
Lj. Majnari}
University »Josip Juraj Strossmayer«, School of Medicine, Department of Family Medicine, Department of Internal
Medicine, Strossmayerova 105, 31000 Osijek, Croatia
e-mail: ljiljana.majnaric@hi.t-com.hr.
EPIDEMIOLOGIJA I KLINI^KE ZNA^AJKE UPALNIH BOLESTI CRIJEVA U ZADARSKOJ
@UPANIJI, HRVATSKA
S A @ E T A K
Prikazani su rezultati retrospektivne populacijske studije, 2000–2010, o upalnim bolestima crijeva, ulceroznom koli-
tisu (UC) i Cronovoj bolesti (CD), za Zadarsku `upaniju, te uspore|eni s podacima iz svijeta i komparativnim podacima
za Primorsko-Goransku i Vukovarsko-Srijemsku `upaniju. Prosje~ne stope incidencije (na 100 000) su iznosile 8.2 i 8.4,
za UC i CD, ponaosob. Stope prevalencije, na kraju razdoblja pra}enja, su iznosile 133.9 za UC i 111 za CD. Za obje
bolesti je registriran stalni rast stopa incidencije, za CD izrazitije u drugoj polovini vremena pra}enja, 2006–2010. Stope
prevalencije su kontinuirano rasle za obje bolesti, s tim da su vrijednosti za UC prevazilazile one za CD. Rezultati
dobiveni usporedbom podataka izme|u `upanija govore u prilog hipotezi o Zadarskoj `upaniji kao o podru~ju koje se
brzo razvija, a protiv su postojanja Sjever-Jug gradijenta izme|u Vukovarsko-Srijemske i Zadarske `upanije.
